Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Life events and escape in conversion disorder.

Nicholson TR, Aybek S, Craig T, Harris T, Wojcik W, David AS, Kanaan RA.

Psychol Med. 2016 Sep;46(12):2617-26. doi: 10.1017/S0033291716000714. Epub 2016 Jul 5.

2.

Emotional Experience and Awareness of Self: Functional MRI Studies of Depersonalization Disorder.

Medford N, Sierra M, Stringaris A, Giampietro V, Brammer MJ, David AS.

Front Psychol. 2016 Jun 2;7:432. doi: 10.3389/fpsyg.2016.00432. eCollection 2016.

3.

Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology.

David AS, Ajnakina O.

World Psychiatry. 2016 Jun;15(2):129-30. doi: 10.1002/wps.20327. No abstract available.

4.

Draft Genome Sequence of Microdochium bolleyi, a Dark Septate Fungal Endophyte of Beach Grass.

David AS, Haridas S, LaButti K, Lim J, Lipzen A, Wang M, Barry K, Grigoriev IV, Spatafora JW, May G.

Genome Announc. 2016 Apr 28;4(2). pii: e00270-16. doi: 10.1128/genomeA.00270-16.

5.

Psychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection Analysis.

Rossi R, Zammit S, Button KS, Munafò MR, Lewis G, David AS.

PLoS One. 2016 Apr 27;11(4):e0153148. doi: 10.1371/journal.pone.0153148. eCollection 2016.

6.

Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: A consecutive case series.

Jay EL, Nestler S, Sierra M, McClelland J, Kekic M, David AS.

Psychiatry Res. 2016 Jun 30;240:118-22. doi: 10.1016/j.psychres.2016.04.027. Epub 2016 Apr 13.

7.

A Randomised Controlled Trial of Neuronavigated Repetitive Transcranial Magnetic Stimulation (rTMS) in Anorexia Nervosa.

McClelland J, Kekic M, Bozhilova N, Nestler S, Dew T, Van den Eynde F, David AS, Rubia K, Campbell IC, Schmidt U.

PLoS One. 2016 Mar 23;11(3):e0148606. doi: 10.1371/journal.pone.0148606. eCollection 2016.

8.

Cognitive load and autonomic response patterns under negative priming demand in depersonalization-derealization disorder.

Lemche E, Sierra-Siegert M, David AS, Phillips ML, Gasston D, Williams SC, Giampietro VP.

Eur J Neurosci. 2016 Apr;43(7):971-8. doi: 10.1111/ejn.13183. Epub 2016 Feb 15.

9.

Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.

Pollak TA, Beck K, Irani SR, Howes OD, David AS, McGuire PK.

Psychopharmacology (Berl). 2016 May;233(9):1605-21. doi: 10.1007/s00213-015-4156-y. Epub 2015 Dec 14. Review.

10.

Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial.

Bartholdy S, McClelland J, Kekic M, O'Daly OG, Campbell IC, Werthmann J, Rennalls SJ, Rubia K, David AS, Glennon D, Kern N, Schmidt U.

Trials. 2015 Dec 3;16:548. doi: 10.1186/s13063-015-1069-3.

11.

Effect of high-potency cannabis on corpus callosum microstructure.

Rigucci S, Marques TR, Di Forti M, Taylor H, Dell'Acqua F, Mondelli V, Bonaccorso S, Simmons A, David AS, Girardi P, Pariante CM, Murray RM, Dazzan P.

Psychol Med. 2016 Mar;46(4):841-54. doi: 10.1017/S0033291715002342. Epub 2015 Nov 27.

12.

Are neurological and psychiatric disorders different?

David AS, Nicholson T.

Br J Psychiatry. 2015 Nov;207(5):373-4. doi: 10.1192/bjp.bp.114.158550.

13.

Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.

Henderson C, Knapp M, Yeeles K, Bremner S, Eldridge S, David AS, O'Connell N, Burns T, Priebe S.

PLoS One. 2015 Oct 8;10(10):e0138816. doi: 10.1371/journal.pone.0138816. eCollection 2015.

14.

Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study.

Trotta A, Murray RM, David AS, Kolliakou A, O'Connor J, Di Forti M, Dazzan P, Mondelli V, Morgan C, Fisher HL.

Schizophr Bull. 2016 Mar;42(2):464-75. doi: 10.1093/schbul/sbv131. Epub 2015 Sep 15.

15.

Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.

Law S, Haddad PM, Chaudhry IB, Husain N, Drake RJ, Flanagan RJ, David AS, Patel MX.

Ther Adv Psychopharmacol. 2015 Aug;5(4):214-23. doi: 10.1177/2045125315588032.

16.

Psychotic Experiences, Working Memory, and the Developing Brain: A Multimodal Neuroimaging Study.

Fonville L, Cohen Kadosh K, Drakesmith M, Dutt A, Zammit S, Mollon J, Reichenberg A, Lewis G, Jones DK, David AS.

Cereb Cortex. 2015 Dec;25(12):4828-38. doi: 10.1093/cercor/bhv181. Epub 2015 Aug 18.

17.

A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups.

Gong Q, Dazzan P, Scarpazza C, Kasai K, Hu X, Marques TR, Iwashiro N, Huang X, Murray RM, Koike S, David AS, Yamasue H, Lui S, Mechelli A.

Schizophr Bull. 2015 Nov;41(6):1266-75. doi: 10.1093/schbul/sbv109. Epub 2015 Aug 11.

18.

Overcoming the effects of false positives and threshold bias in graph theoretical analyses of neuroimaging data.

Drakesmith M, Caeyenberghs K, Dutt A, Lewis G, David AS, Jones DK.

Neuroimage. 2015 Sep;118:313-33. doi: 10.1016/j.neuroimage.2015.05.011. Epub 2015 May 14.

19.

Emotion-motion interactions in conversion disorder: an FMRI study.

Aybek S, Nicholson TR, O'Daly O, Zelaya F, Kanaan RA, David AS.

PLoS One. 2015 Apr 10;10(4):e0123273. doi: 10.1371/journal.pone.0123273. eCollection 2015.

20.

Abnormal cardiovascular sympathetic and parasympathetic responses to physical and emotional stimuli in depersonalization disorder.

Owens AP, David AS, Low DA, Mathias CJ, Sierra-Siegert M.

Front Neurosci. 2015 Mar 26;9:89. doi: 10.3389/fnins.2015.00089. eCollection 2015.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk